MarketPeel
Insider Trading Intelligence
AR

Alise Reicin

TECX
CHIEF EXECUTIVE OFFICER · TECTONIC THERAPEUTIC, INC. · CIK 0001757533
FILING MIX · LIFETIME86%/14%
BUYS
25
SELLS
4
TOTAL VALUE
$271.9K
COMPANIES
3
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
448,623
AVG SELL PX
$23.84
TRADE KIND
SHOWING 29 / 29
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Alise Reicin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-4.04%-0.82%-3.22%-3.22%
14d1+100.00%+5.00%+0.17%+4.83%+4.83%
30d1+100.00%+51.34%-4.29%+55.63%+55.63%
60d1+100.00%+36.12%-0.85%+36.97%+36.97%
90d1+100.00%+27.03%+6.68%+20.35%+20.35%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TECX · 310,623 shares · as of Jun 20, 2026
077,887155,774233,660311,54720252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 4 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Executive Officer
924$30.34$28.0K310,623Jun 20, 2026Jun 23, 2026View →
IMTX
IMMATICS N.V.
PURCHASEGRANT
Stock grant
48,00048,000Jun 16, 2026Jun 18, 2026View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
90,00090,000Jun 4, 2026Jun 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
76,500311,547Mar 4, 2026Mar 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
69,25069,250Mar 4, 2026Mar 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASE
Chief Executive Officer
2,500$21.10$52.8K127,030Feb 11, 2026Mar 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASE
Chief Executive Officer
2,500$21.10$52.8K237,547Feb 11, 2026Feb 12, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Executive Officer
4,104$23.22$95.3K235,047Feb 4, 2026Feb 10, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Executive Officer
10,96622,957Dec 31, 2025Jan 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASE
Chief Executive Officer
10,966$2.38$26.1K239,151Dec 31, 2025Jan 5, 2026View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
14,700228,185Sep 25, 2025Sep 29, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
26,71026,710Sep 25, 2025Sep 29, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
SALE
Chief Executive Officer
859$19.81$17.0K213,485Jun 20, 2025Jun 24, 2025View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
80,00080,000Jun 5, 2025Jun 9, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
36,047214,344Feb 4, 2025Feb 6, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
101,953101,953Feb 4, 2025Feb 6, 2025View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
6,0006,000Dec 4, 2024Dec 6, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
11,717178,297Dec 4, 2024Dec 6, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
166,580166,580Jun 20, 2024Jun 24, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
289,600289,600Jun 20, 2024Jun 24, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
124,530124,530Jun 20, 2024Jun 24, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
33,92333,923Jun 20, 2024Jun 24, 2024View →
TECX
TECTONIC THERAPEUTIC, INC.
PURCHASEGRANT
Stock grant
23,38023,380Jun 20, 2024Jun 24, 2024View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
54,27854,278Jun 6, 2024Jun 7, 2024View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
65,00065,000Jun 6, 2024Jul 15, 2024View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
65,00065,000Jun 8, 2023Jun 9, 2023View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
65,00065,000Jun 6, 2022Jun 8, 2022View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
11,79511,795Feb 3, 2021Feb 18, 2021View →
SANA
SANA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
7,0007,000Feb 3, 2021Feb 5, 2021View →
Other insiders · TECX
Loading peer insiders…
About this filer
CIK 0001757533
ROLE
Chief Executive Officer
PRIMARY
TECX
COMPANIES
3
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001757533DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback